Authors: Broglio, F Benso, A Arvat, E Aimaretti, G Gottero, C Granata, R Boghen, MF Bobbio, M Camanni, F Ghigo, E

Citation: F. Broglio et al., Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy, J ENDOC INV, 23(8), 2000, pp. 520-525

Authors: Bisi, G Podio, V Valetto, FR Broglio, F Bertuccio, G Del Rio, G Boghen, MF Berti, F Muller, EE Ghigo, E

Citation: G. Bisi et al., Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults, EUR J ENDOC, 140(4), 1999, pp. 322-327

Authors: Bisi, G Podio, V Valetto, MR Broglio, F Bertuccio, G Del Rio, G Arvat, E Boghen, MF Deghenghi, R Muccioli, G Ong, H Ghigo, E

Citation: G. Bisi et al., Acute cardiovascular and hormonal effects of GH and hexarelin, a syntheticGH-releasing peptide, in humans, J ENDOC INV, 22(4), 1999, pp. 266-272

Authors: Broglio, F Fubini, A Morello, M Arvat, E Aimaretti, G Gianotti, L Boghen, MF Deghenghi, R Mangiardi, L Ghigo, E

Citation: F. Broglio et al., Activity of GH/IGF-I axis in patients with dilated cardiomyopathy, CLIN ENDOCR, 50(4), 1999, pp. 417-430

Authors: Bisi, G Podio, V Valetto, MR Broglio, F Bertuccio, G Aimaretti, G Pelosi, E Del Rio, G Muccioli, G Ong, H Boghen, MF Deghenghi, R Ghigo, E

Citation: G. Bisi et al., Cardiac effects of hexarelin in hypopituitary adults, EUR J PHARM, 381(1), 1999, pp. 31-38